RESPONSE PLUS HOLDING |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.95 AED | -0.75% |
|
-3.42% | -13.76% |
| Apr. 26 | Response Plus Unit Closes Prometheus Medical Acquisition | MT |
| Mar. 22 | UAE-based Response Plus Posts Improved FY23 Profit, Revenue | MT |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 1,930 | 1,238 | 916 |
| Enterprise Value (EV) 1 | 1,858 | 1,093 | 855.5 |
| P/E ratio | 29.7 x | 42.2 x | 18.5 x |
| Yield | - | 5.17% | - |
| Capitalization / Revenue | 6.43 x | 3.86 x | 2.65 x |
| EV / Revenue | 6.19 x | 3.4 x | 2.47 x |
| EV / EBITDA | 26.7 x | 30.3 x | 14.3 x |
| EV / FCF | -11,740,783 x | 9,697,479 x | -15,427,976 x |
| FCF Yield | -0% | 0% | -0% |
| Price to Book | 7.75 x | 5.55 x | 3.98 x |
| Nbr of stocks (in thousands) | 200,000 | 200,000 | 200,000 |
| Reference price 2 | 9.650 | 6.190 | 4.580 |
| Announcement Date | 2/17/22 | 3/24/23 | 3/21/24 |
1AED in Million2AED
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net sales 1 | 2.807 | 300.1 | 321.1 | 346.1 |
| EBITDA 1 | -2.278 | 69.45 | 36.11 | 59.86 |
| EBIT 1 | -3.751 | 65.76 | 30.45 | 50.78 |
| Operating Margin | -133.64% | 21.91% | 9.48% | 14.67% |
| Earnings before Tax (EBT) 1 | -3.877 | 65.01 | 29.75 | 49.96 |
| Net income 1 | -3.877 | 65.01 | 29.31 | 49.39 |
| Net margin | -138.15% | 21.66% | 9.13% | 14.27% |
| EPS 2 | -0.0194 | 0.3250 | 0.1466 | 0.2469 |
| Free Cash Flow | - | -158.2 | 112.7 | -55.45 |
| FCF margin | - | -52.71% | 35.08% | -16.02% |
| FCF Conversion (EBITDA) | - | - | 312.02% | - |
| FCF Conversion (Net income) | - | - | 384.37% | - |
| Dividend per Share | - | - | 0.3200 | - |
| Announcement Date | 2/17/22 | 2/17/22 | 3/24/23 | 3/21/24 |
1AED in Million2AED
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | - |
| Net Cash position 1 | 0.09 | 72.4 | 145 | 60.5 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | -158 | 113 | -55.5 |
| ROE (net income / shareholders' equity) | - | 58.9% | 12.4% | 21.8% |
| ROA (Net income/ Total Assets) | - | 26.3% | 6.13% | 10.4% |
| Assets 1 | - | 247 | 478.3 | 476.6 |
| Book Value Per Share 2 | -0.1400 | 1.250 | 1.110 | 1.150 |
| Cash Flow per Share 2 | 0 | 0.1600 | 0.4800 | 0.2300 |
| Capex 1 | 0.02 | 6.31 | 16.2 | 30.9 |
| Capex / Sales | 0.56% | 2.1% | 5.04% | 8.92% |
| Announcement Date | 2/17/22 | 2/17/22 | 3/24/23 | 3/21/24 |
1AED in Million2AED
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -13.76% | 215M | |
| +15.32% | 84.55B | |
| +12.36% | 26.01B | |
| -6.65% | 17.28B | |
| +13.32% | 16.57B | |
| +6.74% | 14.28B | |
| -16.11% | 13.16B | |
| +16.00% | 9.52B | |
| +26.11% | 8.75B | |
| +27.22% | 7.13B |
- Stock Market
- Equities
- RPM Stock
- Financials Response Plus Holding
